Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EE001 in Cardiac Insufficiency
NCT06884111Phase 1Completed
- Sponsor
- HygeianCells BioMedical
- Start
- Jun 2024
- Primary completion
- Dec 2024
- Modality
- Unknown
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of EE001 in heart failure (HF), sponsored by HygeianCells BioMedical. Primary endpoint: Safety assessment at Day 7. Started Jun 2024; status: completed.
02
Drugs
EE001
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06884111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06884111.